Todd Bertoch

Selective Inhibition of Na _V 1.8 with VX-548 for Acute Pain

J. W. Jones, Darin Correll, Sandra Lechner et al. · New England Journal of Medicine · 2023 · 266 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials

Todd Bertoch, Dominick S. D’Aunno, Jessica McCoun et al. · Anesthesiology · 2025 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Suzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain

Jessica McCoun, Peter Winkle, Daneshvari Solanki et al. · Journal of Pain Research · 2025 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of the Efficacy of HSK3486 and Propofol for Induction of General Anesthesia in Adults: A Multicenter, Randomized, Double-blind, Controlled, Phase 3 Noninferiority Trial

Tong J. Gan, Todd Bertoch, Ashraf S. Habib et al. · Anesthesiology · 2023 · 45 citations · Full text

Medicine, Anesthesiology, Pharmacology +16